{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:02:28Z","timestamp":1791255748157,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1RR033173"],"award-info":[{"award-number":["UL1RR033173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG028383"],"award-info":[{"award-number":["P30 AG028383"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neurobiolaging.2012.09.012","type":"journal-article","created":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T12:09:17Z","timestamp":1349870957000},"page":"1051-1059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Neuroinflammatory phenotype in early Alzheimer's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Tiffany L.","family":"Sudduth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.64.1.18","article-title":"Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease","volume":"64","author":"Bowler","year":"1998","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"Extended results of the Alzheimer's disease anti-inflammatory prevention trial","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib5","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pctr.0010041","article-title":"The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen","volume":"1","author":"Breitner","year":"2006","journal-title":"PLoS Clin. Trials"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-3-27","article-title":"Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD","volume":"3","author":"Colton","year":"2006","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/187152710791012053","article-title":"Assessing activation states in microglia","volume":"9","author":"Colton","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0197-4580(01)00292-5","article-title":"Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice","volume":"22","author":"DiCarlo","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1189\/jlb.0406249","article-title":"Biochemical and functional characterization of three activated macrophage populations","volume":"80","author":"Edwards","year":"2006","journal-title":"J.\u00a0Leukocyte Biol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatric Res."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000107700","article-title":"Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment","volume":"4","author":"Guerreiro","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0404.2000.00314.x","article-title":"Immediate causes of death of demented and non-demented elderly","volume":"176","author":"Kammoun","year":"2000","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib15","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.292.23.2901","article-title":"Mixed dementia: emerging concepts and therapeutic implications","volume":"292","author":"Langa","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.109.147389","article-title":"Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program\/Honolulu Asia Aging Study","volume":"55","author":"Launer","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-7-56","article-title":"LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice","volume":"7","author":"Lee","year":"2010","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","article-title":"Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial","volume":"27","author":"Leoutsakos","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-011-0047-z","article-title":"Vascular cognitive impairment: disease mechanisms and therapeutic implications","volume":"8","author":"Levine","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2012.09.012_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.archger.2009.09.028","article-title":"Is there a relationship between high C-reactive protein (CRP) levels and dementia?","volume":"49","author":"Mancinella","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ana.22550","article-title":"Systemic inflammation induces axon injury during brain inflammation","volume":"70","author":"Moreno","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity","volume":"66","author":"Nelson","year":"2007","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","article-title":"Contribution of systemic inflammation to chronic neurodegeneration","volume":"120","author":"Perry","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/156720512801322591","article-title":"University of Kentucky Sanders-Brown Healthy Brain Aging volunteers: donor characteristics, procedures, and neuropathology","volume":"9","author":"Schmitt","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/geront\/41.6.716","article-title":"Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project","volume":"41","author":"Schmitt","year":"2001","journal-title":"Gerontologist"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib34","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","article-title":"Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study","volume":"59","author":"Shah","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181f52db1","article-title":"Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques","volume":"75","author":"Sonnen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib36","doi-asserted-by":"crossref","first-page":"e31993","DOI":"10.1371\/journal.pone.0031993","article-title":"Lithium treatment of APPSwDI\/NOS2-\/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype","volume":"7","author":"Sudduth","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000078501","article-title":"Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review","volume":"23","author":"Szekely","year":"2004","journal-title":"Neuroepidemiol."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib38","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.09.012_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J.\u00a0Neuroinflammation"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:48:25Z","timestamp":1777528105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801200468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S019745801200468X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.09.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammatory phenotype in early Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}